Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03090542 · ClinicalTrials.gov registry record · NA
GPur- Luminating Oral Cholesterol Kinetics Pilot Study
A NA study of Cholesterol Absorption, sponsored by Canadian Collaborative Research Network.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03090542 is a NA study of Cholesterol Absorption that has completed, run by Canadian Collaborative Research Network. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03090542, a NA study of Cholesterol Absorption, has completed, sponsored by Canadian Collaborative Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
In healthy subjects not receiving or requiring lipid lowering therapy and who do not have diabetes, the use of clinoptilolite (GPUR) will result in a reduction of absorbed dietary cholesterol observed over 6 days of therapy.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT clinoptilolite
Study Locations (1)
Georgia
- Atlanta Heart Specialists - Cumming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2018-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03090542
The ClinicalTrials.gov registry entry for NCT03090542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Canadian Collaborative Research Network, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cholesterol Absorption appearing as the primary indexed condition, and to 1 intervention - of which clinoptilolite is the first listed.
NCT03090542 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03090542 about?
NCT03090542 is a clinical study titled "GPur- Luminating Oral Cholesterol Kinetics Pilot Study". In healthy subjects not receiving or requiring lipid lowering therapy and who do not have diabetes, the use of clinoptilolite (GPUR) will result in a reduction of absorbed dietary cholesterol observed over 6 days of therapy.
What is the current status of trial NCT03090542?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-06-01. Estimated completion is 2018-01-15.
What conditions does trial NCT03090542 study?
This clinical trial studies the following conditions: Cholesterol Absorption.
What interventions are being tested in trial NCT03090542?
The interventions under investigation include: clinoptilolite (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03090542?
This trial is sponsored by Canadian Collaborative Research Network, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03090542 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.